おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Greer Capital Advisors
investment firm
About
GCA provides capital for private equity projects that act as a catalyst for economic growth in their community.
- Birmingham,Alabama,United States
- http://www.greercap.com
Highlights
Details
- Operating Status
- Active
- Also Known As
- GCA
- Investor Type
- Venture Capital
GCA provides capital for private equity projects that act as a catalyst for economic growth in their community. This includes multiple roles and a range of activities based on four key principles.
Investments
Number of Investments
Number of Lead Investments
3
1
Greer Capital Advisors has made 3 investments. Their most recent investment was on
Mar 31, 2012, when ViroXis raised $1.01M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Mar 31, 2012
ViroXis
|
Series Unknown | $1.01M | Biotechnology | — |
|
Jun 7, 2007
PNP Therapeutics
|
Series B | $0.92M | Biotechnology | Yes |
|
Mar 1, 2004
TransMolecular
|
Series C | $33.20M | Biotechnology | — |
Exits
Greer Capital Advisors has had 2 exits. Greer Capital Advisors most notable exits include ViroXis , TransMolecular
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Jun 18, 2015 | ViroXis | M&A | Biotechnology | Detail |
| Mar 4, 2011 | TransMolecular | M&A | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
